Red+blue Strategies is a registered federal lobbying firm. For Q3 2026 it reported $1.69M across 24 client reports and lists 7 lobbyists across its filings. Issues include Health Issues, Medicare/Medicaid, Immigration and Veterans.
| Client | Reported | Issues |
|---|---|---|
| PALANTIR TECHNOLOGIES, INC. | $110K | Health Issues |
| CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS | $100K | Health Issues, Medicare/Medicaid |
| HPA MANAGEMENT GROUP INC. | $90K | Medicare/Medicaid |
| GREATER NEW YORK HOSPITAL ASSOCIATION | $80K | Health Issues, Immigration, Medicare/Medicaid |
| AMERICAN HOSPITAL ASSOCIATION | $80K | Health Issues, Medicare/Medicaid |
| GENEDX, LLC | $80K | Defense, Health Issues, Medicare/Medicaid |
| MOUNT SINAI HOSPITALS GROUP, INC | $80K | Health Issues, Immigration, Medicare/Medicaid |
| THE CIGNA GROUP | $80K | Health Issues |
| CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) | $80K | Health Issues, Medicare/Medicaid |
| QUEST DIAGNOSTICS INCORPORATED | $80K | Health Issues |
| CHAPTER | $70K | Medicare/Medicaid |
| GE HEALTHCARE | $70K | Health Issues, Veterans |
| DAVITA INC. | $70K | Health Issues |
| ARCHER AVIATION | $60K | Aviation/Airlines/Airports |
| KAROO HEALTH | $60K | Health Issues, Medicare/Medicaid, Veterans |
| FOUNTAIN HOUSE | $60K | Health Issues |
| PRIME THERAPEUTICS | $60K | Health Issues |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | $60K | Health Issues |
| CAREFIRST BLUECROSS BLUESHIELD | $60K | Health Issues |
| BOSTON MEDICAL CENTER | $60K | Health Issues, Medicare/Medicaid |
| THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA | $60K | Health Issues |
| BAYCARE HEALTH SYSTEM | $60K | Budget/Appropriations, Health Issues, Medicare/Medicaid |
| BLUE CROSS BLUE SHIELD OF MASSACHUSETTS | $50K | Health Issues |
| HIMS&HERS | $30K | Health Issues |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $4.56M | 24 |
| 2025 | $4.64M | 19 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.